Showing results (341-350 of 552) with videos related to
Sort By:
Pageof 56
American Journal of Clinical Dermatology|July 20, 2022
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc AnalysisJonathan I Silverberg, David N Adam, Matthew Zirwas, et al.Journal of the American Academy of Dermatology|December 9, 2019
Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitisJonathan I Silverberg, Jin-Shei Lai, Paras P Vakharia, et al.Journal of the American Academy of Dermatology|March 1, 2020
Prevalence of asthma in patients with atopic dermatitis: A systematic review and meta-analysisNanna Ravnborg, Danni Ambikaibalan, Gaurav Agnihotri, et al.The Pediatric Infectious Disease Journal|January 26, 2013
Asthmatic children have increased specific anti-Mycoplasma pneumoniae IgM but not IgG or IgE-values independent of history of respiratory tract infectionTamar A Smith-Norowitz, Jonathan I Silverberg, Melanie Kusonruksa, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2025
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by AgeMichael J Cork, Mette Deleuran, Bob Geng, et al.Dermatology and Therapy|September 1, 2023
Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysisJonathan I Silverberg, H Chih-Ho Hong, Brian M Calimlim, et al.The Journal of Dermatological Treatment|October 27, 2024
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and GermanyNicholas Durno, Pablo Arija, Krystallia Pantiri, et al.Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 15, 2022
Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Norma P M Rubini, Mario C Pires, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2018
Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitisJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.Pageof 56